2 completed, 2 recruiting, 1 terminated. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 2, Recruiting 2, Terminated 1 |
Follow Soft Tissue Sarcomas: new trials by email Literature Review of Soft Tissue Sarcomas trials Research Report on Soft Tissue Sarcomas
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors SHY-ONC6 - Advanced or Metastatic Solid Tumors, Triple Negative Breast Cancer (TNBC) | Phase 1 | Recruiting | SHY Therapeutics | 30 | 2026-06-24 | 2026-10-22 |
| A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas Pazopanib, Trabectedin, Ipilimumab - Soft Tissue Sarcomas | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 18 | 2026-06-12 | 2026-08-06 |
| A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors Magnetic resonance high intensity focused ultrasound, Lyso-thermosensitive liposomal doxorubicin - Pediatric Cancer, Solid Tumors | Phase 1 | Terminated | AeRang Kim | 2 | 2016-10-01 | 2023-08-29 |
| Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. PSMA/PRAME - Ovarian, Melanoma | Phase 1 | Completed | Mannkind Corporation | 12 | 2007-02-01 | 2010-08-03 |
| Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS) IPI-504 - Gastrointestinal Stromal Tumors, Soft Tissue Sarcomas | Phase 1 | Completed | Infinity Pharmaceuticals, Inc. | 63 | 2005-12-01 | 2011-01-06 |
Sarcoma (5) · Mesothelioma (2) · Stomach Neoplasms (2) · Anus Neoplasms (1) · Biliary Tract Neoplasms (1) · Bone Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Neuroendocrine (1) · Carcinoma, Non-Small-Cell Lung (1) · Colonic Neoplasms (1) · Endometrial Neoplasms (1) · Esophageal Neoplasms (1) · Gallbladder Neoplasms (1) · Gastrointestinal Stromal Tumors (1)
Neoplasms by Histologic Type (5) · Neoplasms, Connective and Soft Tissue (5) · Digestive System Diseases (4) · Digestive System Neoplasms (4) · Neoplasms (4) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Neoplasms by Site (3) · Neoplasms, Glandular and Epithelial (3) · Adenocarcinoma (2) · Adenoma (2) · Breast Diseases (2) · Bronchial Neoplasms (2) · Carcinoma (2) · Carcinoma, Bronchogenic (2)
Ipilimumab (1) · Nivolumab (1) · Trabectedin (1) · pazopanib (1) · tanespimycin (1)
AeRang Kim (1) · Infinity Pharmaceuticals, Inc. (1) · M.D. Anderson Cancer Center (1) · Mannkind Corporation (1) · SHY Therapeutics (1)
United States (5) · Canada (1)
AeRang Kim, MD, PhD (1) · Brandon D Brown, MD (1) · George D Demetri, MD, PhD (1)